![Robert Wills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Wills
Président chez
MILESTONE PHARMACEUTICALS INC.
Fortune : 185 150 $ au 31/05/2026
Profil
Dr. Robert J.
Wills is an Independent Director at Alpha Cognition, Inc., a Chairman at Milestone Pharmaceuticals, Inc. and an Independent Director at Oncternal Therapeutics, Inc. He is on the Board of Directors at Alpha Cognition, Inc., Oncternal Therapeutics, Inc., Go Therapeutics, Inc., Parion Sciences, Inc. and Feldan Bio, Inc. Dr. Wills was previously employed as a Member-Emerging Companies Section by Biotechnology Innovation Organization, a Chairman by CymaBay Therapeutics, Inc., an Executive Chairman by GTx, Inc., a Vice President-Alliance Management by Janssen Pharmaceuticals, Inc., and a Senior Vice President-Global Development by Johnson & Johnson.
He also served on the board at Oncternal Oncology, Inc. He received his undergraduate degree from the University of Wisconsin, a graduate degree from the University of Wisconsin and a doctorate degree from The University of Texas at Austin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALPHA COGNITION INC 0,07 % | 24/04/2026 | 15 000 ( 0,07 % ) | 92 850 $ | 31/05/2026 |
| 10/06/2026 | 65 000 ( 0,05 % ) | 92 300 $ | 31/05/2026 |
Postes actifs de Robert Wills
| Sociétés | Poste | Début |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 07/06/2019 |
| MILESTONE PHARMACEUTICALS INC. | Président | - |
| ALPHA COGNITION INC. | Directeur/Membre du Conseil | 07/04/2025 |
Parion Sciences, Inc.
 Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops new treatments for serious diseases in multiple therapeutic areas | Directeur/Membre du Conseil | 01/12/2015 |
Go Therapeutics, Inc.
 Go Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Directeur/Membre du Conseil | 01/09/2017 |
Feldan Bio, Inc.
 Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces and supplies recombinant proteins for therapeutic and research purposes | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert Wills
| Sociétés | Poste | Fin |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Président | 22/03/2024 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | 01/07/2021 |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Président | 01/06/2019 |
| ░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Robert Wills
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Parion Sciences, Inc.
Parion Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops new treatments for serious diseases in multiple therapeutic areas | Commercial Services |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Feldan Bio, Inc.
Feldan Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops, produces and supplies recombinant proteins for therapeutic and research purposes | Health Technology |
Oncternal Oncology, Inc.
 Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company and manufactures pharmaceutical products | Health Technology |
Go Therapeutics, Inc.
Go Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
Oncternal Therapeutics, Inc.
 Oncternal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology company that manufactures pharmaceutical products | Health Technology |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
